PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Clinical trials for PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.

Never miss a new study

Get alerted when new PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

Sign up with your email to follow new studies for PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug could help kids with rare immune disease survive until transplant

Disease control Recruiting now

This study tests a drug called ruxolitinib as the first treatment for children with primary haemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening immune disorder. The goal is to see if ruxolitinib, given with steroids, can help children survive long enough to rec…

Matched conditions: PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 16, 2026 12:54 UTC

PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Get alerted when new PRIMARY HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

New drug could help kids with rare immune disease survive until transplant